Recombinant soluble FcγRII inhibits immune complex precipitation
- 1 December 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 102 (3) , 620-625
- https://doi.org/10.1111/j.1365-2249.1995.tb03862.x
Abstract
SUMMARY: Control of IgG immune complex formation and deposition is important in determining the nature and extent of subsequent immune effector responses, and appears to be aberrant in some autoimmune diseases. In this study we demonstrate that recombinant soluble FCγRII (rsFcγRII) is an effective modulator of immune complex formation, delaying immune precipitation in a manner which is dose-dependent, and can be specifically inhibited by anti-FcγRII MoAb Fab’ fragments. This inhibitory role in immune precipitation also provides a possible mechanist explanation for our previous demonstration of the efficacy or rsFcγRII as an inhibitor of immune complex-induced inflammation in the Arthus reaction in vivo. RSFcγRH inhibited immune complex precipitation in two different experimental systems. First, rsFc7RII inhibited the precipitation of 125I-bovine serum albumin (BSA)-anti-BSA complexes in a dose-dependent manner, while an irrelevant protein (soybean trypsin inhibitor) had no effect on the precipitation of the immune complexes. Moreover. RsFcγRII inhibited the precipitation of ovalbumin (OVA) anti-OVA complexes as determined by turbidimetric analysis, where the inhibition of immune complex precipitation by rsFc7RII was dose-dependent and was specifically blocked by prior ineubation with Fab’ fragments of a blocking MoAb to FcγRII. RSFcγRII could inhibit the precipitation of BSA anti-BSA complexes in the presence of excess bystander IgG and did not inhibit complement-mediated prevention of immune precipitation, demonstrating that rsFcγRII did not block C1 binding to the BSA anti-BSA complex. Unlike complement. RSFC7RIL could not cause re-solubilization of pre-formed precipitated BSA- anti-BSA complexes. Soluble FcγRS have been detected in biological fluids of normal and inflammatory disease patients., yet the role of SFcγR is still unclear. However, they now play a potential role in the modulation of immune complex solubility.Keywords
This publication has 35 references indexed in Scilit:
- Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.The Journal of Experimental Medicine, 1993
- IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.The Journal of Experimental Medicine, 1991
- The role of Fc:Fc interactions in insoluble immune complex formation and complement activationMolecular Immunology, 1988
- The binding site for C1q on IgGNature, 1988
- IgG Fc Receptors in Sera from Patients with Rheumatoid Arthritis and Systemic Lupus ErythematosusScandinavian Journal of Rheumatology, 1988
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986
- Co-operative interaction of subcomponents of the first component of complement with IgG: A functional defect of dimeric Facb from rabbit IgGMolecular Immunology, 1985
- Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.Journal of Clinical Investigation, 1978
- Studies on the mechanism of solubilization of immune precipitates by serum.The Journal of Experimental Medicine, 1976
- THE CUTANEOUS REACTION TO SOLUBLE ANTIGEN-ANTIBODY COMPLEXESThe Journal of Experimental Medicine, 1958